Microbubble-assisted ultrasound for drug delivery in the brain and central nervous system

Advances in Experimental Medicine and Biology

Volumn 880, Issue , 2016, Pages 293-308

  Burgess, Alison ^a   Hynynen, Kullervo ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer s disease; Blood brain barrier; Drug delivery; Focused ultrasound; Glioblastoma

Indexed keywords

ARTICLE; BLOOD BRAIN BARRIER; BLOOD SPINAL CORD BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEM; HUMAN; MEMBRANE FORMATION; MICROBUBBLE; MICROBUBBLE ASSISTED ULTRASOUND; NON INVASIVE PROCEDURE; NONHUMAN; PATIENT SAFETY; PERMEABILITY BARRIER; PRIORITY JOURNAL; RISK ASSESSMENT; RODENT MODEL; ULTRASOUND; ANIMAL; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG DELIVERY SYSTEMS; HUMANS; MICROBUBBLES; ULTRASONICS;

EID: 84962755280     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-22536-4_16     Document Type: Article

References (108)

1. Abbott NK, Patabendige AA, Doman DE, Yusof SR, Begley DG (2010) Structure and function of the bloodbrain barrier. Neurobiol Dis 37:13–25.
2. Alkins R, Burgess A, Ganguly M, Francia G, Kerbel R, Wels WS, Hynynen K (2013) Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 73:1892–1899.
3. Alonso A, Reinz E, Fatar M, Hennerici MG, Meairs S (2011) Clearance of albumin following ultrasoundinduced blood-brain barrier opening is mediated by glial but not neuronal cells. Brain Res 1411:9–16.
4. Alonso A, Reinz E, Leuchs B, Kleinschmidt J, Fatar M, Geers B, Lentacker I, Hennerici MG, de Smedt SC, Meairs S (2013) Focal delivery of AAV2/1-transgene into the rat brain by localized ultrasound induced BBB opening. Mol Ther Nucleic Acids 2:e73.
5. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C (2010) Pericytes regulate the blood-brain barrier. Nature 468:557–561.
6. Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N (2012) Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 7:e45783.
7. Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N (2013) Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of bloodtumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 169:103–111.
8. Bakay L, Ballantine HT Jr, Hueter TF, Sosa D (1956) Ultrasonically produced changes in the blood-brain barrier. AMA Arch Neurol Psychiatry 76:457.
9. Baseri B, Choi JJ, Deffieux T, Samiotaki G, Tung YS, Olumolade O, Small SA, Morrison B III, Konofagou EE (2012) Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles. Phys Med Biol 57:65–81.
10. Bing KF, Howles GP, Qi Y, Palmeri ML, Nightingale KR (2009) Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and definity in mice. Ultrasound Med Biol 35:1298–1308.
11. Burgess A, Ayala-Grosso CA, Ganguly M, Jordão JF, Aubert I, Hynynen K (2011) Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One 6:e27877.
12. Burgess A, Huang Y, Querbes W, Sah DW, Hynynen K (2012) Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release 163:125–129.
13. Burgess A, Dubey S, Yeung S, Hough O, Eterman N, Aubert I, Hynynen K (2014) Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the bloodbrain barrier and improves pathologic abnormalities and behavior. Radiology 273:736–745.
14. Chen H, Konofagou EE (2014) The size of blood-brain barrier opening induced by focused ultrasound is dictated by acoustic pressure. J Cereb Blood Flow Metab 34:1197–1204.
15. Chen PY, Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Lyu LA, Tseng IC, Feng LY, Tsai HC, Chen SM, Lu YJ, Wang JJ, Yen TC, Ma YH, Wu T, Chen JP, Chuang JI, Shin JW, Hseuh C, Wei KC (2010) Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol 12:1050–1060.
16. Chen H, Kreider W, Brayman AA, Bailey MR, Matula TJ (2011) Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 106:034301.
17. Cho CW, Liu W, Cobb N, Henthorn TK, Lillehei K, Christians U (2002) Ultrasound induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells. Pharm Res 19:1123–1129.
18. Cho EE, Drazic J, Ganguly M, Stefanovic B, Hynynen K (2011) Two-photon fluorescence microscopy study of cerebrovascular dynamics in ultrasound-induced blood–brain barrier opening. J Cereb Blood Flow Metab 31:1852–1862.
19. Choi JJ, Pernot M, Small SA, Konofagou EE (2007) Noninvasive transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol 33:95–104.
20. Choi JJ, Wang S, Brown TR, Small SA, Duff KE, Konofagou EE (2008) Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer’s double transgenic mice using focused ultrasound. Ultrason Imaging 30:189–200.
21. Choi JJ, Feshitan JA, Baseri B, Wang S, Tung YS, Borden MA, Konofagou EE (2010) Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans Biomed Eng 57:145–154.
22. Choi JJ, Selert K, Gao Z, Baseri B, Konofagou EE (2011) Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulses lengths and low repetition frequencies. J Cereb Blood Flow Metab 31:725–737.
23. Clement GT, Sun J, Hynynen K (2001) The role of internal reflection in transskull phase distortion. Ultrasonics 39:109–113.
24. Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562–566.
25. Deng CX, Sieling F, Pan H, Cui J (2004) Ultrasoundinduced cell membrane porosity. Ultrasound Med Biol 30:519–526.
26. Deng J, Huang Q, Wang F, Liu Y, Wang Z, Wang Z, Zhang Q, Lei B, Cheng Y (2012) The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. J Mol Neurosci 46:677–687.
27. Diaz RJ, McVeigh PZ, O’Reilly MA, Burrell K, Bebenek M, Smith C, Etame AB, Zadeh G, Hynynen K, Wilson BC, Rutka JT (2014) Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier potential for targeting experimental brain tumours. Nanomedicine 10:1075–1087.
28. Etame AB, Diaz RJ, O’Reilly MA, Smith CA, Mainprize TG, Hynynen K, Rutka JT (2012) Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 8:1133–1142.
29. Fan CH, Ting CY, Lin HJ, Wang CH, Liu HL, Yen TC, Yeh CK (2013a) SPIO-conjugated, doxorubicinloaded microbubbles for concurrent MRI and focusedultrasound enhanced brain-tumor drug delivery. Biomaterials 34:3706–3715.
30. Fan CH, Ting CY, Liu HL, Huang CY, Hsieh HY, Yen TC, Wei KC, Yeh CK (2013b) Antiangiogenic-targeting drugloaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 34:2142–2155.
31. Fenstermacher J, Gross P, Sposito N, Acuff V, Pettersen S, Gruber K (1988) Structural and functional variations in capillary systems within the brain. Ann N Y Acad Sci 529:21–30.
32. Fry WJ, Fry FJ (1960) Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans Med Electron 7:166–181.
33. Goertz DE, Wright C, Hynynen K (2010) Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound. Ultrasound Med Biol 36:916–924.
34. Goldmann EE (1909) Die aussere und innere Sekretion des gesunden und kranken Organismus im Lichte det ‘vitalenFarbung’. Beitraege Klinischen Chirurgie 64:192–265.
35. Gross ME, Nelson ET, Mone MC, Hansen HJ, Sklow B, Glasgow RE, Scaife CL (2011) A comparison of postoperative outcomes utilizing a continuous preperitoneal infusion versus epidural for midline laparotomy. Am J Surg 202:765–770.
36. Hawkins BT, Davis TP (2005) The blood-brain barrier/ neurovascular unit in health and disease. Pharmacol Rev 57:173–185.
37. Hosseinkhah N, Hynynen K (2012) A three-dimensional model of an ultrasound contrast agent gas bubble and its mechanical effects on microvessels. Phys Med Biol 57:785–808.
38. Hsu PH, Wei KC, Huang CY, Wen CJ, Yen TC, Liu CL, Lin YT, Chen JC, Shen CR, Liu HL (2013) Noninvasive and targeted gene delivery into the brain using microbubblefacilitated focused ultrasound. PLoS One 8:e57682.
39. Hynynen K, Jolesz FA (1998) Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 24:275–283.
40. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220:640–646.
41. Hynynen K, Clement GT, McDannold N, Vykhodtseva N, King R, White PJ, Vitek S, Jolesz FA (2004) 500- element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med 52:100–107.
42. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vyhodtseva N (2005) Local and reversible blood- brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24:12–20.
43. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz FA, Sheikov N (2006) Focal disruption of the blood-brain barrier due to 260 kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 105: 445–454.
44. Jalali S, Huang Y, Dumont DJ, Hynynen K (2010) Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol 10:114.
45. Janzer RC, Raff MC (1987) Astrocytes induce bloodbrain barrier properties in endothelial cells. Nature 325:253–257.
46. Jordão JF, Ayala-Grosso CA, Markham K, Huang Y, Chopra R, McLaurin J, Hynynen K, Aubert I (2010) Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer’s disease. PLoS One 5:e10549.
47. Jordão JF, Thévenot E, Markham-Coultes K, Scarcelli T, Weng YQ, Xhima K, O’Reilly M, Huang Y, McLaurin J, Hynynen K, Aubert I (2013) Amyloid-ß plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol 248:16–29.
48. Killian DM, Hermeling S, Chikhale PJ (2007) Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system. Drug Deliv 14:25–31.
49. Kinoshita M, McDannold N, Jolesz FA, Hynynen K (2006) Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasoundinduced blood-brain barrier disruption. Proc Natl Acad Sci U S A 103:11719–11723.
50. Kniesel U, Wolburg H (2000) Tight junctions of the bloodbrain barrier. Cell Mol Neurobiol 20:1347–1357.
51. Krizanac-Bengez L, Mayberg MR, Janigro D (2004) The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 26: 846–853.
52. Lionetti V, Fittipaldi A, Agostini S, Giacca M, Recchia FA, Picano E (2009) Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. Ultrasound Med Biol 35:136–143.
53. Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, Hynynen K, Lozano AM (2013) MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 12:462–468.
54. Liu HL, Pan CH, Ting CY, Hsiao MJ (2010a) Opening of the blood-brain barrier by low-frequency (28 kHz) ultrasound: a novel pinhole assisted mechanical scanning device. Ultrasound Med Biol 36:325–335.
55. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, Huang CY, Wang JJ, Yen TC, Wei KC (2010b) Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255:415–425.
56. Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614–628.
57. Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE (2011) Noninvasive, transient and selective bloodbrain barrier opening in non-human primates in vivo. PLoS One 6:e22598.
58. McDannold N, Vykhodsteva N, Jolesz FA, Hynynen K (2004) MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit. Magn Reson Med 51: 913–923.
59. McDannold N, Vykhodtseva N, Raymond S, Jolesz F, Hynynen K (2005) MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 31:1527–1537.
60. McDannold N, Vykhodtseva N, Hynynen K (2006) Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 51:793–807.
61. McDannold N, Vykhodtseva N, Hynynen K (2007) Use of ultrasound pulses combined with definity for targeted blood-brain barrier disruption; a feasibility study. Ultrasound Med Biol 33:584–590.
62. McDannold N, Vykhodtseva N, Hynynen K (2008a) Blood-brain barrier disruption by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34:834–840.
63. McDannold N, Vykhodtseva N, Hynynen K (2008b) Effects of acoustic parameters and ultrasound. Ultrasound Med Biol 34:930–937.
64. McDannold N, Clement GT, Black P, Jolesz F, Hynynen K (2010) Transcranial magnetic resonance imaging–guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. J Neurosurg 66:323–332.
65. McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS (2012) Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 72:3652–3663.
66. Mei J, Cheng Y, Song Y, Yang Y, Wang F, Liu Y, Wang Z (2009) Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound. J Ultrasound Med 28:871–880.
67. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst WH, Kooiman K, de Jong N, Musters RJ, Deelman LE, Kamp O (2009) Ultrasound and microbubble- targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 104:679–687.
68. Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR, Mourad PD (2002) High-intensity focused ultrasound selectively disrupts the bloodbrain barrier in vivo. Ultrasound Med Biol 28:389–400.
69. Musch MW, Walsh-Reitz MM, Chang EB (2006) Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption. Am J Physiol Gastrointest Liver Physiol 290:222–231.
70. Nhan T, Burgess A, Cho EE, Stefanovic B, Lilge L, Hynynen K (2013) Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy. J Control Release 172:274–280.
71. Nyborg WL (2001) Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med Biol 27:301–333.
72. O’Reilly MA, Hynynen K (2012) Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263:96–106.
73. O’Reilly MA, Hynynen K (2013) A super-resolution ultrasound method for brain vascular mapping. Med Phys 40:100701.
74. O’Reilly MA, Waspe AC, Ganguly M, Hynynen K (2010) Focused ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate. Ultrasound Med Biol 37:587–594.
75. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14.
76. Pardridge WM (2012) Drug transport across the blood- brain barrier. J Cereb Blood Flow Metab 32:1959–1972.
77. Pardridge WM, Boado RJ (2012) Reengineering biopharmaceuticals for targeted delivery across the bloodbrain barrier. Methods Enzymol 503:269–292.
78. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N (2012) Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 163:277–284.
79. Patrick JT, Nolting MN, Goss SA, Dines KA, Clendenon JL, Rea MA, Heimburger RF (1990) Ultrasound and the blood-brain barrier. Adv Exp Med Biol 267:369–381.
80. Pires A, Fortuna A, Alves G, Falcao A (2009) Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12:288–311.
81. Rapoport SI (2001) Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 10:1809–1818.
82. Raymond SB, Skoch J, Hynynen K, Bacskai BJ (2007) Multiphoton imaging of ultrasound/optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab 27:393–403.
83. Raymond SB, Treat LH, Dewey JD, McDannold NJ, Hynynen K, Bacskai BJ (2008) Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer’s disease mouse models. PLoS One 3:e2175.
84. Samiotaki G, Konofagou EE (2013) Dependence of the reversibility of focused- ultrasound-induced bloodbrain barrier opening on pressure and pulse length in vivo. IEEE Trans Ultrason Ferr 60:2257–2265.
85. Samiotaki G, Vlachos F, Tung YS, Konofagou EE (2012) A quantitative pressure and microbubble-size dependence study of focused ultrasound induced bloodbrain barrier opening reversibility in vivo using MRI. Magn Reson Med 67:769–777.
86. Scarcelli T, Jordao JF, O’Reilly MA, Ellens N, Hynynen K, Aubert I (2014) Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice. Brain Stimul 7:304–307.
87. Sedlakova R, Shivers RR, Del Maestro RF (1999) Ultrastructure of the blood-brain barrier in the rabbit. J Submicrosc Cytol Pathol 31:149–161.
88. Shealy CN, Crafts D (1965) Selective alteration of the blood-brain barrier. J Neurosurg 23:484–487.
89. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K (2004) Cellular mechanisms of the bloodbrain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 30: 979–989.
90. Sheikov N, Mcdannold NJ, Sharma S, Hynynen K (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34:1093–1104.
91. Thévenot E, Jordão JF, O’Reilly MA, Markham K, Weng YQ, Foust KD, Kaspar BK, Hynynen K, Aubert I (2012) Targeted delivery of scAAV9 to the brain using MRI-guided focused ultrasound. Human Gene Ther 23:1144–1155.
92. Tilling T, Engelbertz C, Decker S, Korte D, Hüwel S, Galla HJ (2002) Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cells cultures. Cell Tissue Res 310:19–29.
93. Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, Wei KC, Yeh CK (2012) Concurrent blood-brain barrier opening and local drug delivery using drug carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 33:704–712.
94. Traub O, Ishida T, Ishida M, Tupper JC, Berk BC (1999) Shear-stress-mediated extracellular signal-related kinase activation is regulated by sodium in endothelial cells. Potential role for a voltage-dependent sodium channel. J Biol Chem 274:20144–20150.
95. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRIguided focused ultrasound. Int J Cancer 121:901–907.
96. Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by mri-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38:1716–1725.
97. Tufail Y, Matyushov A, Baldwin N, Tauchmann ML, Georges J, Yoshihiro A, Tillery SIH, Tyler WJ (2010) Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron 66:681–694.
98. Tung YS, Marquet F, Teichert T, Ferrera V, Konofagou EE (2011) Feasibility of noninvasive cavitation-guided blood-brain barrier opening using focused ultrasound and microbubbles in nonhuman primates. Appl Phys Lett 98:163704
99. van Wamel A, Kooiman K, Harteveld M, Emmer M, ten Cate FJ, Versluis M, de Jong N (2006) Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112:149–155.
100. Vlachos F, Tung YS, Konofagou EE (2011) Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magn Reson Med 66:821–830.
101. Vykhodtseva N, Hynynen K, Damianou C (1995) Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 21:969–979.
102. Vykhodtseva N, McDannold N, Hynynen K (2008) Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics 48:279–296.
103. Wang F, Shi Y, Lu L, Liu L, Cai Y, Zheng H, Liu X, Yan F, Zou C, Sun C, Shi J, Lu S, Chen Y (2012) Targeted delivery of GDNF through the blood–brain barrier by MRI-guided focused ultrasound. PLoS One 7:e52925.
104. Wang S, Samiotaki G, Olumolade O, Feshitan JA, Konofagou EE (2014) Microbubble type and distribution dependence of focused ultrasound-induced blood- brain barrier opening. Ultrasound Med Biol 40:130–137.
105. Weng JC, Wu SK, Yang FY, Tseng WY (2010) Pulse sequence and timing of contrast-enhanced MRI for assessing blood-brain barrier disruption after transcranial focused ultrasound in the presence of haemorrhage. J Magn Reson Imaging 31:1323–1330.
106. White E, Woolley M, Bienemann A, Johnson DE, Wyatt M, Murray G, Taylor H, Gill SS (2010) A robust MRIcompatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal model. J Neurosci Methods 195:78–87.
107. Yang FY, Fu WM, Chen WS, Yeh WL, Lin WL (2008) Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain barrier disruption. Ultrason Sonochem 15:636–643.
108. Yang FY, Lin YS, Kang KH, Chao TK (2011) Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J Control Release 150:111–116